BioNTech SE ADR buy stefan
Start price
13.07.20
/
50%
€68.00
Target price
04.11.21
-
Performance (%)
29.94%
End price
27.11.20
€88.36
Summary
This prediction ended on 27.11.20 with a price of €88.36. The prediction had a final performance of 29.94%. stefan has a follow-up prediction for BioNTech SE ADR where he still thinks BioNTech SE ADR is a Buy. stefan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioNTech SE ADR | 7.896% | 7.896% | 243.124% | - |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
According to stefan what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Leading role in innovation
Strong uniques
Positive Image
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Cons
Below average Marketposition
Significant cyclical dependencies
High valuation
Comments by stefan for this prediction
In the thread Biontech SE diskutieren
Heute kam das Fast Track Approval der FDA für den Coronavirus Impfstoff
In the thread Trading Biontech SE
Buy closed
Current prediction by stefan for BioNTech SE ADR
BioNTech SE ADR
Start price
Target price
Perf. (%)
€99.01
02.12.20
02.12.20
€105.00
28.11.24
28.11.24
-20.36%
23.08.24
23.08.24
Leading role in innovation
Strong uniques
Below average Marketposition
Significant cyclical dependencies
Stopped prediction by stefan for BioNTech SE ADR
BioNTech SE ADR
Start price
Target price
Perf. (%)
€88.48
27.11.20
27.11.20
€120.00
13.34%
02.12.20
02.12.20
Leading role in innovation
Strong uniques
Below average Marketposition
Significant cyclical dependencies